Tuesday, 5 September 2017

U.S. judge invalidates Mallinckrodt patents on respiratory treatment

(Reuters) - A federal court in Delaware on Tuesday invalidated patents held by Mallinckrodt Pharmaceuticals on its Inomax respiratory treatment system.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)